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Abstract 
Sixty-six Nigerian patients with ischaemic heart diseases age ranging between 50 -75 years were 
studied. The samples consisted of 42 cases with angina pectoris and 24 cases with myocardial 
infarction, which were proven to suffer from ischaemic heart disease by the presence of clinical 
symptoms, exercise electrocardiogram abnormalities and myocardial enzyme measurement. 
Controls were 36 subjects who did not show any abnormalities in the parameters used. Controls 
and patients were classified into groups based on the presence or absence of risk factors 
(smoking, hypertension, diabetes, hyperlipidaemia, obesity and family history). The mean 
plasma concentrations of vitamins C and E were significantly inversely related to the risks of 
ischaemic heart disease. Smoking was a compounding factor. These findings suggest that some 
populations with high incidence of ischaemic heart disease may benefit from eating diets rich in 
natural antioxidants, particularly vitamins E and C. 
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Free radicals have been incriminated in the 
pathogenesis of myocardial damage during 
ischaemia as well as in the generation of 
atherosclerotic plaques. In both processes, 
membrane damage has been considered to play a 
pivotal role in initiating the cascade process 
leading to the ultimate cellular death of the 
affected tissues. A large body of evidence1 
shows that free radicals are responsible for 
plasma membrane damage and that it is the 
fallouts of these peroxidation processes that 
eventuate in the diverse sequelae of various 
diseases like obesity, diabetes mellitus, arterial 
hypertension and other cardiovascular diseases, 
retinopathy, nephropathy etc2,3. In addition to 
lipids, free radicals attack proteins, enzymes and 
DNA to unleash an avalanche of pathological 
events4. 
 
The oxidative modification of low-density 
lipoprotein (LDL) particles in the arterial 
subendothelium results in structural changes, 
which are postulated to make them more 
atherogenic than native LDL. This then means 
that inhibition of oxidation or modification of 
LDL should retard or inhibit atherosclerosis and 
consequently decrease or prevent the clinical 
sequelae. This is why the use of dietary 
antioxidants to inhibit the oxidation or 
modification of LDL has received increasing 
attention in recent years and has in consequence 
popularized the use of antioxidant food 
supplements to improve life expectancy.  
 
The nutrients that have shown promise as 
protective antioxidants include lipid - soluble 
antioxidants in humans because of their 
association with membrane lipids as well as 
water-soluble vitamins like Vitamin C. Vitamin 
C serves directly as an antioxidant by 
scavenging aqueous peroxyl radicals and 
indirectly by regenerating reduced vitamin E. 
Vitamins C and E as well as uric acid, ubiquinol 
and -carotene (among others) are chain-
breaking antioxidants and could individually halt 
the chain of oxidative reactions that ultimately 
lead to pathology4. The use of these vitamins 
combined with moderate exercise have been 
shown to counteract oxidative stress and also 
lower the level of malondialdehyde, a critical 
marker of oxidative stress 3,5. Since these 
vitamins and other antioxidants are available in 
several food materials in our environment and 
the highest prevalence of cardiovascular disease 
risk factors is observed in adults of low socio-
economic status6, the nutritional and health 
benefits of the current study to a predominantly 
poor population justify the effort.   
 
It is therefore, the purpose of this work to obtain 
an evidence from Imo State, Nigeria that low 
plasma concentrations of vitamins with 
antioxidant properties is related to the risk of 
ischaemic heart disease and then suggest the 
clinical significance of eating diets rich in 
natural antioxidants, the so-called functional 
foods, to this population. This is important 
especially as reports from different parts of the 
world seem to be contradictory7,8. 
 
MATERIALS AND METHODS  
 
Identification and Grouping of Subjects 
Successive patients presenting to General 
Hospital, Owerri and a reputable specialist 
private hospital in Owerri Nigeria between a 
period of eight (8) months were enlisted for the 
study. Sixty-six (66) newly diagnosed patients 
with ischaemic heart disease (32 males and 34 
females) age ranging 50-75 years and 36 
population-based controls (19 males and 17 
females) of the same age brackets were used for 
this study. The samples consisted of 42 cases 
with angina pectoris, and 24 cases with 
myocardial infarction, which were proven to 
suffer from ischaemic heart disease by the 
presence of clinical symptoms, exercise 
electrocardiogram abnormalities and increased 
blood levels of myocardial enzyme (lactate 
dehydrogenase isoenzymes; LDH1 and LDH2). 
Controls were subjects who did not show any 
clinical evidence of ischaemic heart disease, and 
no E.C.G changes.  
 
The subjects were divided into groups based on 
various risk factors as follows: 
 
Smokers: Subjects who smoke regularly and at 
least one cigarette per day or its equivalent as 
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tobacco or has just stopped smoking in the last 
three months prior to the study. 
 
Hypertensives: Subjects that had raised blood 
pressures interpreted as patients with an average 
of 2 diastolic BP measurements in the range of 
95-130 mmHg in the sitting or supine positions. 
 
Diabetics: Subjects that had raised blood sugar 
levels and were placed on diet. 
 
Obese: Subjects that had body mass index (BMI) 
> 30, BMI calculated as weight/height x height.  
 
Hyperlipidaemics: Subjects with LDL 
cholesterol levels > 140 mg/100ml or total 
cholesterol level > 200mg/100ml. 
 
Familial: Subjects with positive family history 
of one or both parents or bloodkin having had 
ischaemic heart disease or died suddenly before 
the age of 55. 
 
Individuals with abnormal liver and kidney 
function parameters or those with peripheral 
blood vessel disorders and acute infections were 
categorized as confounders and therefore 
excluded from the study9. All subjects were 
informed of the rationale for the study and their 
informed obtained prior to the study as required 
by WHO10. 
 
Blood Collection and Biochemical Assays 
Blood samples (5ml each) from the subjects 
were collected into tubes treated with the 
anticoagulant EDTA (1mg/dl) after an overnight 
fast of 10-12hrs. Blood was obtained from 
patients with acute myocardial infarction within 
9-24 hrs after attack. Blood samples from 
healthy subjects who had normal cardiovascular 
function and were resident in Owerri metropolis 
were similarly collected and used as controls. 
The plasma samples obtained by centrifuging 
the whole blood in a Wisperfuge (model 684) 
centrifuge at 2500g for 10 min were used 
immediately11. 
 
Plasma vitamin C was assayed by the 2 – 4 
nitrophenyl-hydrazine methods of Tietz 12 while  
plasma Vitamin E levels were determined based 
on the  ability of  vitamin E to cause a reduction 
of ferric to ferrous ion which them forms a red 
complex with --dipyridyl  as described by 
Tietz13. 
 
Plasma triglyceride level for each sample was 
determined by the method of Mendez et al14. 
Total cholesterol was measured by the method 
of Zak15 while high-density lipoprotein – 
cholesterol (HDL-C) was determined by the 
method of Lopez-Vitrella et al16. Low density 
lipoprotein – cholesterol (LDL-C) was then 
calculated by a modified Friedewald formula17 
based on these measured parameters. Percentage 
plasma lactate dehydrogenase isoenzyme 
activity was determined using the 
polyacrylamide gel electrophoresis method of 
Ditz and Lubrano18. 
 
Statistical Analysis 
All results were analyzed by the Statistical 
Analysis System (SAS) program (SAS Institute, 
Inc. Cary, N. C.) and values were expressed as 
mean ± S.D. Duncan multiple range test was 
used to determine significant differences in the 
plasma concentrations of vitamins C and E, and 
the lipoproteins. Correlation was done using 
Spearman’s correlation statistical method. 
Results with differences at P < 0.05 were 
considered significantly different.  
 
RESULTS AND DISCUSSION 
 
The clinical characteristics of the studied 
population are shown in Table 1.  
 














Sample size 36 42 24 
Age Range 50 – 75 50 – 75 50 – 75 
Male                  19 26 14 
Female  17 16 10 
Smokers 6 14 12 
Hypertensives - 20 14 
Diabetics - 8 4 
Obese 2 6 4 
Hyperlipidaemics - 21 34 
Familial - 10 6 
 
Only subjects with no clinical symptoms or 
predisposing habits were enlisted as controls.  
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Table 2: Plasma vitamin and lipoprotein concentrations in relation to ischaemic heart 
diseases 
Parameters       
  
Control Angina pectoris Myocardial 
infarction 
Vitamin E (mg/L)   10.79 ± 0.96a 7.35 ± 1.35b 7.34 ± 1.11 b 
Vitamin C (mmol/L) 78.4 ± 7.4 a 57.5 ± 5.9 b 54.64 ± 4.8 b 
Total Cholesterol (mg/dl)   167.16 ± 8.18 a 198.98 ± 3.38 b 202.16 ± 3.79 b 
HDL Cholesterol (mg/dl)   51.31 ± 4.55 a 37.54 ± 3.45 b 35.53 ± 2.42 b 
LDL Cholesterol (mg/dl) 98.19 ± 6.83 a 136.04 ± 6.83 b 140.65 ± 4.45 b 
Triglyceride (mg/dl) 99.66 ± 4.81 a 128.46 ± 14.39 b 130.28 ± 11.52 b 
 Results are shown as mean + S.D. Means with different superscripts are significant (P < 0.05). 
 
Table 3: Levels of vitamins E and C in male and female ischaemic heart disease patients. 
Angina pectoris Myocardial infarction Parameters 
Male Female Male Female 
Vitamin C mmol/L 59.25+5.2a     55.7 + 4.4a 56.20 + 3.4a  53.15 + 45a 
Vitamin E g/L 7.08+1.46a 7.78 + 1.07a 7.54 + 1.20a 7.09 + 0.98a 
Results are shown as mean + S.D. Means with different superscripts are significant (P < 0.05). 
Levels of Vitamins C and E in the samples as 
well as the results of lipoprotein determinations 
are represented in Table 2. These results show 
that the mean plasma concentrations of vitamins 
C and E in angina pectoris patients were 57.5 ± 
5.9 mmol/L and 7.35 ± 1.35mg/L respectively 
while the corresponding values in patients with 
myocardial infarction were 54.64 ±4.8mmol/L 
and 7.34 ±1.11mg/L respectively. These values 
are significantly (P< 0.05) lower than the  
control group values of 78.4 ± 7.9mmol/L and 
10.79 ± 0.96mg/L for vitamin C and E 
respectively. There were no statistically 
significant gender-related differences between 
male and female patients with angina pectoris as 
well as between those with myocardial 
infarction is as shown in Table 3. 
 
The results of the lipid profile showed 
significantly (P < 0.05) higher levels of total 
cholesterol, LDL – cholesterol and 
triglyceride in both angina pectoris and 
myocardial infarction patients relative to the 
corresponding values for the control group. 
Contrarily, the HDL – cholesterol levels in 
these disease conditions were significantly 
(P < 0.05) lower than the value for the 
control group. These observations agree 
with our results in an earlier study on this 
population9. The findings are also in 
consonance with some other reports for 
Nigerians19 as well as for the report for 
Indians20.  
 
Table 4: Plasma vitamin concentrations in smokers 
and non-smokers. 




Smokers 49.2 + 2.52* 9.42 + 1.56 
Non-Smokers 86.22+4.3* 11.05+1.33 
* = Significant at P < 0.05 
Table 4 shows the relative results of these 
measured parameters between smokers and non-
smokers. Cigarette smokers had significantly (P 
< 0.05) lower levels of vitamin C than subjects 
who had never smoked. There was however, no 
observed significant difference in vitamin E 
levels between smokers and non-smokers among 
the studied population. These observations do 
not agree completely with other reports. 
Cigarette smoke as well as various gaseous 
pollutants are known to induce oxidative stress 
which in turn depletes the levels of antioxidants 
including vitamins A, C and E. The non-
significant increase in Vitamin E level observed 
in this study may be as a result of several 
factors. In addition to scavenging reactive 
oxygen and reactive nitrogen species, vitamin C 
is known to possess the ability to regenerate 
other antioxidants such as a-tocopherol (vitamin 
E), glutathione, urate and B-carotene from their 
respective radical species1. Vitamin C may 
therefore have had a regenerating or sparing 
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effect on vitamin E, hence our current 
observations. This however needs to be further 
investigated.  
 
Furthermore, correlation analysis (not shown in 
the tables) show that plasma vitamin E 
concentrations were inversely related to total 
cholesterol (r = - 0.51; P < 0.05) and to 
triglycerides (r = - 0.45; P < 0.05) but positively 
related to HDL cholesterol (r = 0.47; P < 0.05). 
Similarly, plasma vitamin C concentrations were 
inversely related to total cholesterol (r = - 0.46; 
P < 0.05) but not to HDL-Cholesterol. Low 
levels of HDL-Cholesterol and high levels of 
triglycerides, total cholesterol and LDL-
Cholesterol are known to be independent 
markers of the possibility of cardiovascular 
events22. Our findings therefore support this 
position.  
 
The relevance of our study on the possible 
correlation between vitamins C and E and 
ischaemic heart diseases in our locality is 
heightened when considered against the 
background that the evidence from laboratory 
and epidemiological studies linking low plasma 
vitamin antioxidants with ischaemic heart 
diseases (IHD) has been equivocal. In Europe, 
the study of healthy middle-aged men in 
Scotland, Finland and Italy showed no consistent 
correlation between plasma concentrations of 
carotene or vitamins A, C and E and the 
incidence of IHD among the population7. In 
Netherlands, a multicentre case-control study on 
alpha-tocopherol and beta-carotene 
concentrations in coronary heart diseases (CHD) 
showed that low alpha-tocopherol concentration 
was not associated with the risk of myocardial 
infarction8. These findings mean that vitamin 
levels can not explain the incidence of coronary 
heart disease among these studied populations. 
 
Other studies23 have however shown a clear 
inverse relationship between plasma vitamins C 
and E concentrations and CHD.  In India, it was 
shown that the inverse relation between CAD 
and low plasma vitamin C concentration was 
substantially reduced after adjustment for 
smoking and diabetes while Vitamin E level 
remained independently and inversely related to 
the risk of IHD after adjustment for age, 
smoking, and diabetes. 
 
Having established that the levels of the 
antioxidant vitamins C and E inversely correlate 
with ischaemic heart diseases in our study area 
of Imo State, Nigeria and considering that due to 
a concert of socio-economic factors apparently 
healthy people may not seek medical attention 
until the late stage of ischaemic pathology, we 
recommend that serum levels of vitamins C and 
E among the population be used as a preliminary 
tool for diagnosing and managing ischaemic 
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